Teva Pharmaceutical Industries (TEVA) earnings per share (EPS)

Earnings per share · fiscal 2025
$1.21

Teva Pharmaceutical Industries (TEVA) reported diluted earnings per share of $1.21 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$1.45. Figures as of 18 Nov 2026, 00:28 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
$1.21
Growth, 10 years
−4.0% a year
Highest on record
$3.67fiscal 2010
Lowest on record
-$16.26fiscal 2017
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Teva Pharmaceutical Industries earnings per share (EPS), in more detail

Over the ten fiscal years to 2025 diluted earnings per share shrank at a compound 4.0% a year. Across the 19 fiscal years on record (2007–2025), the highest was $3.67 in fiscal 2010 and the lowest -$16.26 in fiscal 2017.

History · 19 fiscal years

Earnings per share by fiscal year

Teva Pharmaceutical Industries earnings per share (EPS), year by year

Teva Pharmaceutical Industries (TEVA) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025$1.21—
2024-$1.45—
2023-$0.50—
2022-$2.12 657.9% down
2021$0.38—
2020-$3.64—
2019-$0.91—
2018-$2.35—
2017-$16.26 23,328.6% down
2016$0.07 96.2% down
2015$1.82 48.9% down
2014$3.56 138.9% up
2013$1.49 33.8% down
2012$2.25 27.2% down
2011$3.09 15.8% down
2010$3.67 64.6% up
2009$2.23 197.3% up
2008$0.75 68.2% down
2007$2.36—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Teva Pharmaceutical Industries and comparable companies
CompanyEarnings per shareFiscal year
Medline MDLN$1.432025
Humana HUM$9.842025
Agilent Technologies A$4.572025
Teva Pharmaceutical Industries TEVA$1.212025
BeOne Medicines ONC$2.472025
Waters WAT$10.762025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TEVA

Teva Pharmaceutical Industries, figure by figure

Teva Pharmaceutical Industries (TEVA) overview: price, valuation and scorecardAll health care companies by market value

Teva Pharmaceutical Industries earnings per share (EPS): questions and answers

What is Teva Pharmaceutical Industries's diluted earnings per share?

Teva Pharmaceutical Industries (TEVA) reported diluted earnings per share of $1.21 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$1.45.

What is the growth rate of Teva Pharmaceutical Industries's diluted earnings per share?

Over the ten fiscal years to 2025 diluted earnings per share shrank at a compound 4.0% a year.

What are the highest and lowest diluted earnings per share figures on record for Teva Pharmaceutical Industries?

Across the 19 fiscal years on record (2007–2025), the highest was $3.67 in fiscal 2010 and the lowest -$16.26 in fiscal 2017.

How is Teva Pharmaceutical Industries's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Teva Pharmaceutical Industries (TEVA) earnings per share (EPS)”, data as of 18 November 2026. https://funkfolio.com/stock/TEVA/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.